Fluorouracil selectively enriches stem-like cells in the lung adenocarcinoma cell line SPC

Tumor Biology

Volumn 34, Issue 3, 2013, Pages 1503-1510

  Shi, Mu Mu ^a,b   Xiong, Yan Lei ^a   Jia, Xin Shan ^a   Li, Xin ^a,c   Zhang, Li ^d   Li, Xiao Lei ^a   Wang, En Hua ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

5 Fluorouracil; Cancer stem cells; Lung adenocarcinoma cell; Side population (SP) cells

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CD133 ANTIGEN; CELL MARKER; FLUOROURACIL; OCTAMER TRANSCRIPTION FACTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; CARCINOGENICITY; CELL CYCLE S PHASE; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EXPOSURE; DRUG MECHANISM; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VIVO STUDY; LUNG ADENOCARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIDE POPULATION CELL; STEM CELL; WESTERN BLOTTING;

EID: 84878699574     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0675-5     Document Type: Article

References (52)

1. Jemal A, Tiwaei RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54:8-29.
2. + liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. Cell Stem Cell. 2011;9:50-63.
3. Dalerba P, Dylla SJ, Park IK, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA. 2007;104:58-63.
4. Prince ME, Sivanandan R, Kaczorowski A, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA. 2007;104:973-8.
5. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007;445:106-10.
6. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003;100:3983-8.
7. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 1996;183:1797-806.
8. Sarkadi B, Ozvegy-Laczka C, Nemet K, Varadi A. ABCG2 - a transporter for all seasons. FEBS Lett. 2004;567:116-20.
9. Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med. 2001;7:1028-34.
10. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, et al. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci USA. 2006;103:11154-9.
11. Kondo T, Setoguchi T, Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA. 2004;101:781-6.
12. Haraguchi N, Utsunomiya T, Inoue H, et al. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells. 2006;24:506-13.
13. Chiba T, Kita K, Zheng YW, et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology. 2006;44:240-51.
14. Chen JS, Pardo FS, Wang-Rodriguez J, et al. EGFR regulates the side population in head and neck squamous cell carcinoma. Laryngoscope. 2006;116:401-6.
15. Ho MM, Ng AV, Lam S, Hung JY. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 2007;67:4827-33.
16. Boiani M, Scholer HR. Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol. 2005;6:872-84.
17. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell. 1998;95:379-91.
18. Pesce M, Scholer HR. Oct3/4: gatekeeper in the beginnings of mammalian development. Stem Cells. 2001;19:271-8.
19. Jin T, Branch DR, Zhang X, Qi S, Youngson B, et al. Examination of POU homeobox gene expression in human breast cancer cells. Int J Cancer. 1998;81:104-12.
20. Wang P, Branch DR, Bali M, Schultz GA, Goss PE, et al. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells. Biochem J. 2003;375:199-205.
21. Monk M, Holding C. Human embryonic genes re-expressed in cancer cells. Oncogene. 2001;20:8085-91.
22. Gidekel S, Pizov G, Bergman Y, Pikarsky E. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell. 2003;4:361-70.
23. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 2005;65:5506-11.
24. Chiou SH, Yu CC, Huang CY, et al. Positive correlations of Oct3/4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res. 2008;14:4085-95.
25. Chen YC, Hsu HS, Chen YW, et al. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One. 2008;3:e2637.
26. Vera, Adele M, Richard D, et al. Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One. 2008;3:e3077.
27. Yao Zhi-fang, Xiao Gao-fang, Shi Jun-wen, et al. Construction of A lentiviral expression vector harboring human Sox2 and EGFP genes. J Trop Med. 2010-03.
28. Hussenet T, Dali S, Exinger J, Monga B, Jost B, et al. SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. PLoS One. 2010;5:e8960.
29. Yuan P, Kadara H, Behrens C, Tang X, Woods D, et al. Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung. PLoS One. 2010;5:e9112.
30. Zheng X, Cui D, Xu S, Brabant G, et al. Doxorubicin fails to eradicate cancer stem cells derived from anaplastic thyroid carcinoma cells: characterization of resistant cells. Int J Oncol. 2010;37:307-15.
31. Bacher G, Nickel B, Emig P, et al. D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vivo, shows efficacy toward multidrug-resistant tumor cells, and lacks neurotoxicity. Cancer Res. 2001;61:392-9.
32. Chemotherapy causes delayed severe neural damage, study shows. BioMed Central/J Biol. Science Daily. 2008-4-22 (2008-4-30).
33. Longley DB, Harkin DP, Johnston PG. 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003;3:330-8.
34. Sun Y, Ren Y, Fang Z, et al. Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases. Am Soc Clin Oncol. 2010;30:4616-20.
35. Goodell MA, Rosenzweig M, Kim H, et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med. 1997;3:1337-45.
36. + and ABCG2-cancer cells are similarly tumorigenic. Cancer Res. 2005;65:6207-19.
37. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414:105-11.
38. Vescovi AL, Galli R, Reynolds BA. Brain tumour stem cells. Nat Rev Cancer. 2006;6:425-36.
39. Cheradame S, Etienne MC, Chazal M, et al. Relevance of tumoral folylpolyglutamate synthetase and reduced folates for optimal 5-fluorouracil efficacy: experimental data. Eur J Cancer. 1997;33:950-9.
40. Cheshier SH, Morrison SJ, Liao X, et al. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc Natl Acad Sci USA. 1999; 3120-5.
41. Nygren JM, Bryder D, Jacobsen SE. Prolonged cell cycle transit is a defining and developmentally conserved hemopoietic stem cell property. J Immunol. 2006;177:201-8.
42. Dunnwald M, Chinnathambi S, Alexandrunas D, Bickenbach JR. Mouse epidermal stem cells proceed through the cell cycle. J Cell Physiol. 2003;195:194-201.
43. Blagosklonny MV. Target for cancer therapy: proliferating cells or stem cells. Leukemia. 2006;20:385-91.
44. Yu F, Yao H, Zhu P, et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell. 2007;131:1109-23.
45. + cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell. 2010;6:603-15.
46. Song N, Jia X-S, Jia L-L, et al. Expression and role of Oct3/4, Nanog and Sox2 in regeneration of rat tracheal epithelium. Cell Prolif. 2010;43:49-55.
47. Jec JA, Polard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer. 2009.
48. Ma XB, Jia XS, Liu YL, Wang LL, Sun SL, Song N, et al. Expression and role of notch signaling in the regeneration of rat tracheal epithelium. Cell Prolif. 2009;42:15-28.
49. Eramo A, Loti F, Sete G, et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 2008;15:504-14.
50. Meng X, Li M, Wang X, et al. Both CD133+ and CD133- subpopulations of A549 and H446 cells contain cancer-initiating cells. Cancer Sci. 2009;100:1040-6.
51. Deyev IE, Polanovsky OL. The Oct genes and Oct proteins. Mol Biol. 2004;38:48-55.
52. Karoubi G, Gugger M, Schmid R, Dutly A. OCT3/4 expression in human non-small cell lung cancer: implications for therapeutic. Interact Cardiovasc Thorac Surg. 2009;8:393-7.